DKDoaa Elsayed Kamal

Doaa Elsayed Kamal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Doaa Elsayed Kamal has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical outcome of ultrasonographic detected undifferentiated synovitis in patients with arthralgia

    by Mohamed A. Mortada, Doaa E. Kamal, Samah M. Alian

    Background: In the early stages of rheumatic diseases, individuals may present with nonspecific musculoskeletal symptoms (such as arthralgia) in the absence of clinical synovitis. Ultrasound (US) looks potentially helpful, particularly in the absence of symptomatic arthritis. This research aims to study the clinical outcomes of undifferentiated synovitis detected by ultrasound in patients who complain of arthralgia and their predicting factors. Results: From 174 patients with arthralgia, 42% of cases went into remission, and 58% remained as persistent inflammatory arthritis (PIA) (26.4% persisted as undifferentiated arthritis, 31.6% differentiated into specific rheumatic diseases of whom 9.2% became rheumatoid arthritis, 6.3% developed spondyloarthropathy, and other diseases) after 2 years of follow-up. Regression analysis showed that patients with Power Doppler (PD) grade (I or II), grayscale (GS) synovitis grade (II or III), and GS synovitis ≥ grade II in one wrist were significant predictors for PIA in undifferentiated arthralgia’s patients. Conclusions: Approximately 60% of patients with arthralgia developed inflammatory arthritis (IA) after 2 years of follow-up, with 77% of them having US synovitis at the onset of the study. A positive PD signal, grade (II or III) GS synovitis, or ≥ grade II at one wrist were all independently related to the development of PIA in arthralgia patients.


  • Open Access

    Safety and efficacy of monthly high-dose vitamin D3 supplementation in children and adolescents with sickle cell disease

    by Diana Hanna, Doaa E. Kamal, Hebatallah M. Fawzy, Reham Abd Elkhalek

    Little is known about the impact of vitamin D supplementation on hand grip strength (HGS) and health-related quality of life (HRQoL) in children and adolescents with sickle cell disease (SCD). We aimed to evaluate the safety and efficacy of monthly high-dose vitamin D3 supplementation and its implications on bone mineral density (BMD), HGS, and HRQoL in patients with SCD and healthy controls. The study included 42 children with SCD and 42 healthy matched controls. The study participants were supplemented with high-dose monthly oral vitamin D3. Changes in the serum level of 25(OH) vitamin D3, maximum HGS, and BMD from baseline to 6 months were assessed, and the HRQoL questionnaire and Childhood Health Assessment Questionnaire (CHAQ) were used to evaluate the functional capacity. At baseline, SCD subjects had poorer growth status indicated by negative Z scores. Suboptimal BMD was detected by significantly lower Z score, and lower HGS and worse HRQL parameters were found compared to the controls (P < 0.001). Median 25(OH) vitamin D3 was significantly lower in SCD patients compared to controls (16.5 vs. 28 ng/mL, respectively (P < 0.001)). After 6 months of vitamin D supplementation, there was significant improvement in the DEXA Z-score (P < 0.001), limitation of physical health (P = 0.02), pain scores (P < 0.001), and CHAQ grades (P = 0.01) in SCD patients. A significant improvement in HGS (P < 0.001 and P = 0.005) as well as the CHAQ score (P < 0.001 and P = 0.003) was detected in the SCD group and controls, respectively. There were no reported clinical adverse events (AEs) or new concomitant medications (CMs) during the study duration, and safe levels of Ca and 25 (OH) D3 were observed at 3 and 6 months for both groups. There was a significant positive correlation between HGS and total physical score (r = 0.831, P < 0.001) and a negative correlation with CHAQ score (r = − 0.685, P < 0.001). We also detected a significant positive correlation between vitamin D levels at 6 months and HGS (r = 0.584, P < 0.001), pain score (r = 0.446, P < 0.001), and a negative correlation with CHAQ score (r = − 0.399, P < 0.001). Conclusion: Monthly oral high-dose vitamin D supplementation was safe and effective in improving vitamin D levels, HGS, and HRQoL in SCD children and healthy subjects, and BMD scores in SCD patients. Further randomized controlled trials are warranted to assess an optimal dosing strategy and to investigate the impact on clinically significant outcomes in children and adolescents with SCD and their healthy counterparts. Trial registration: ClinicalTrials.gov, identifier NCT06274203, date of registration: 23/02/2024, retrospectively registered. What is known:• Several studies have reported a high prevalence of vitamin D deficiency and suboptimal bone mineral density (BMD) in sickle cell disease (SCD) patients.• Musculoskeletal dysfunction is reported in SCD patients with a negative impact on physical activity and health-related quality of life (HRQL).• Little is known regarding the impact of vitamin D3 supplementation in children and adolescents with SCD. What is new:• We found that monthly oral high-dose vitamin D3 supplementation was safe, tolerated, and effective in improving serum vitamin D levels, HGS, BMD scores, and HRQL in SCD patients.


  • Serum interleukin 29 in Rheumatoid Arthritis and Systemic Lupus Erythematosus patients and its association with disease activity.

    by Amal Bakry Abdelsattar, Merna Mohamed Hazem, Marwa Shabana, Doaa Elsayed Kamal

    Background: Interleukin-29 (IL-29) is a recently identified cytokine that has sparked considerable academic interest due to its importance in inflammation, and autoimmune diseases and hence as an avenue for potential therapy creation and disease monitoring. This research sought to determine the role of IL29 in (RA and SLE) and its relationship to disease activity. Methodology: A Case-control study including 144 participants, 48 in each group (RA, SLE, and control. Levels of serum IL-29 in both patients and controls were measured by Human Interleukin 29 (ELISA). Results: IL-29 serum levels in patients with RA and SLE were significantly higher than in the control group. Moreover, there is a highly significant value of IL29 in RA patients compared to SLE patients p0.05. At the same time, in SLE there was a significant difference in serum IL29 value regarding SLEDAI grading scores p<0.001. Conclusion: This research provides data on the relationship between IL-29 and SLE and RA, demonstrating higher IL-29 serum levels in all patients compared to controls. IL-29 may act as a pro-inflammatory cytokine and contribute to the development of RA and SLE. It was also linked to lupus activity.

  • Open Access

    Fragmented QRS complex, highly sensitive CRP, and fibrinogen in early detection of asymptomatic cardiac involvement in systemic lupus erythematosus

    by Doaa E. Kamal, Dalia S. Fahmi, Noha A. Abdelsalam, Doaa M. Elsayed, Eman H. Seddik, Lobna I. Kotb

    Background: Patients with systemic lupus erythematosus (SLE) have an increased risk of developing cardiovascular illnesses. Asymptomatic affection might exist, so early diagnosis can improve the outcome. Aim: The purpose of this study was to determine the importance of highly sensitive C-reactive protein, fragmented QRS, and fibrinogen levels in identifying subclinical cardiac involvement in SLE patients, as well as how these variables relate to disease activity. Results: Regarding hs-CRP and fibrinogen, there were significant differences between the SLE and control group, with a higher frequency of fQRS in the lupus group. The lupus group was divided into 2 subgroups: 44 patients with fragmented QRS in ECG (83%) and 9 patients with normal QRS (17%) with a higher mean value of hs-CRP and fibrinogen level (58.76 ± 70.15, 18.54 ± 26.79) and low HDL (53.37 ± 10.37) in those with fQRS ( +). The sensitivity and specificity of hs-CRP at a cut of level (3.5 mg/L) for fQRS in SLE patients were 75.5%, and 71.7%, respectively. Regression analysis showed hs-CRP and were significant predictors for fQRS changes in SLE patients. Conclusions: A more thorough evaluation of SLE patients with fQRS complexes with hs-CRP and fibrinogen is important with close follow-up for the detection of subclinical cardiac involvement in SLE. Also, SLE activity is linked to fQRS and fibrinogen. Therefore, we advise using them for additional medical care for lupus.


  • Open Access

    Falls and fear of falling: an underestimated sequelae in Behçet’s disease

    by Doaa E. Kamal, Rofaida A. Hassan, Amany M. AbdAllah, Dalia I. Mostafa

    Background: Behçet’s disease (BD) is an inflammatory autoimmune disorder. Balance is a multifactorial process that is ultimately affected in BD leading to frequent falls. Fear of falling (FOF) is a significant risk factor for falls. The study aimed to evaluate the risk of falls and FOF in BD and their relations to disease activity and damage. Results: In BD patients, the history of falls and FOF was 65.6% and 48.4%, respectively. The Berg Balance Scale was low in BD patients (P = 0.003). Falls and fear of falling showed significant relations with the disease activity and disease damage (P < 0.001). There were significant relations between fallers with arthritis (P = 0.003) and active neurological affection (P = 0.004) than non-fallers. A higher balance scale significantly independently decreases the risk of falls (AOR = 0.79, P = 0.005) and FOF (AOR = 0.904, P = 0.039); however, high BD damage and disease duration increase the risk with AOR = 2.364, P = 0.009 and AOR = 0.769, P = 0.088, respectively. Conclusion: Arthritis and active neurological affection are significantly related to falls and FOF; also, FOF is significantly related to active uveitis. Impaired balance, long disease duration, and high disease damage score are significant risk factors for falls and FOF in BD.

  • Open Access

    The role of the Beclin-1: a gene related to autophagy in rheumatoid arthritis

    by Shymaa A. Sarhan, Asmaa Ahmed Saad Hassan, Nora M. Said, Doaa E. Kamal

    Background: Rheumatoid arthritis (RA) is a chronic autoimmune disorder. Autophagy, a regulator of cell homeostasis, can impact innate and adaptive immune cells activation and contribute to the pathogenesis of RA. The purpose of this study was to assess the significance of autophagy in RA, by investigating the autophagy signaling Beclin-1 in RA patients. Results: In RA patients, the Beclin-1 gene expression level was higher than the healthy controls with a statistically highly significant difference (P < 0. 001) where the gene expression mean was 3.33 ± 0.45 in patients and 0.98 ± 0.070 in controls. There was a significant positive correlation between Beclin-1 gene expression and disease duration (p = 0.013*), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and rheumatoid factor (RF) titer (P = 0.018*, 0.027*, and 0.023* respectively). Beclin-1 gene overexpression is significantly correlated with disease activity parameters (DAS 28, patient and physician global health assessment). Furthermore, the Beclin-1 gene overexpression is highly correlated with the disability index, Modified Health Assessment Questionnaire (MHAQ) (P < 0.001). Conclusion: The elevated autophagy-related gene Beclin-1 expression in RA patients can contribute to RA probability, high disease activity, and severity. Therefore, suppressing autophagy may be a therapeutic target for RA.


  • Damage accrual in Behçet disease: Behçet's Syndrome Overall Damage Index (BODI) versus Behçet's Disease Damage Index (BDI)

    by Rofaida A. Hassan, Enas I. Abdelhady, Mona Rabie, Doaa E. Kamal

    Objectives: To assess the validity of Behçet's Syndrome Overall Damage Index (BODI) and Behçet's Disease Damage Index (BDI) as tools for the detection of damage accrual in Behçet's patients compared to Vasculitis Damage Index (VDI). Also, to evaluate the correlation and the interclass correlation among the 3 indices to find out their consistency.Method: A prospective cohort study was carried out on 102 adult Behçet's disease (BD) patients who were diagnosed according to the International Study Group criteria for BD. Disease severity and organ damage were assessed for each patient by VDI, BDI and BODI at baseline and 1‐year follow‐up visits. Damage accrual for each index was defined when there was an increase of at least 1 point (∆ ≥ 1) among the baseline and the follow‐up visits.Results: Correlations among the 3 indices were significant, with (r = 0.835, P < 0.001) between VDI and BODI, (r = 0.835, P < 0.001) between VDI and BDI, and (r = 0.844, P < 0.001) between BODI and BDI scores. A highly significant positive correlation existed between the 3 indices and age and disease duration. In contrast, the correlation with the BD Current Activity Form was non‐significant, which indicates good discriminative validity of the 3 indices. Neuropsychiatric and ocular systems showed a strong interclass correlation among the 3 indices. Regarding detecting damage accrual, BDI was more sensitive than BODI and showed more agreement with VDI.Conclusion: BD damage indices, VDI, BODI and BDI, had good convergent and discriminative validity for the assessment of BD damage. BDI had more sensitivity than BODI to the detection of damage accrual.


  • Open Access

    Validity and reliability of the Arabic version of the Self-Efficacy for Managing Chronic Disease scale in rheumatoid arthritis patients

    by Shymaa A. Sarhan, Doaa E. Kamal, Mona S. Hamed, Dalia I. Mostafa

    Background and objectives: Rheumatoid arthritis (RA) is an autoimmune inflammatory condition that causing disability and affection of patient’s quality of life (QoL). Self-efficacy investigation helps us to detect the requirements of chronically affected patients and evaluation of self-care management programs. The aim of our study was to test validity and reliability of Self-Efficacy for Managing Chronic Disease (SEMCD-Arabic) in RA patients.Method: This study included 248 RA patients, carried out at Rheumatology and Rehabilitation Department. The SEMCD-Arabic Validity was assessed by correlating the SEMCD-Arabic scale with the validated Arabic version of the modified Health Assessment Questionnaire HAQ (MHAQ), the Arabic version of the Multidimensional Assessment of Fatigue (MAF) scale, and the Arabic version of Short Form 36 version 2 for quality of life (SF QoL). Internal consistency, test–retest reliability was assessed.Results: Convergent validity was confirmed by a positive correlation between (physical, mental) component of SF QoL and SEMCD-Arabic (r = 0.918,r = 0.925) respectively, and negative correlation between MAF and SEMCD-Arabic (r = − 0.657) and MHAQ with SEMCD-Arabic (r = − 0.595). Discriminant validity confirmed by a significant negative correlation between visual analogue scale (VAS) for pain, disease activity scale (DAS28), Morning stiffness, patient health, physician health, age, duration, and SEMCD-Arabic (r = − 0.1–0.7) (P < 0.001). Test–retest reliability was estimated which revealed a high interclass correlation coefficient (ICC = 0.87–0.997) indicating excellent agreement and internal consistency is acceptable as the Cronbach’s alpha value (0.660 to 0.78).Conclusion: The SEMCD-Arabic questionnaire can be used as a valid and reliable measure for assessment of patient’s self-efficacy in RA. Key Points• The SEMCD-Arabic questionnaire has a statistically significant validity in correlation with different clinical manifestations MHAQ, SF QoL, and MAF.• The Arabic SEMCD is highly reliable with a Cronbach’s alpha of 0.660 to 0.78.


  • Frequency of the Musculoskeletal Symptoms and associated risk factors among the COVID-19 Patients.

    by Doaa Kamal, Lamiaa Elhawy, Ahmed M. Tawfik, Mohammed Walaa, Shymaa Sarhan

    Background: Fatigue, myalgia, and arthralgia are the typical COVID-19 musculoskeletal symptoms, but their prevalence has not been studied extensively. This study was designed to estimate the frequency of different musculoskeletal symptoms among COVID-19 patients and determine the association between the musculoskeletal symptoms and some Sciodemographic characteristics and the severity of the disease.Method:A cross-sectional study was conducted among 160 (COVID-19) patients attended screening clinic at Zagazig university hospitals during a period from15-4-2020 to 15-7-2020, they were drown by systemic random method. Clinical assessment was done by taking of sociodemographic data, assessment of the severity of COVID symptoms and assessment of the musculoskeletal through Joint assessment and Fatigue assessment.Results: The majority of patients developed fatigue and myalgia (60.0%), arthritis, or arthralgia was reported in (47.5%, 45.0% )of patients had back pain. According to Nordic questionnaire, most of studied patients were suffering from musculoskeletal manifestations at neck, lower back, and knee (55.0%, 54.0% and 50.0%) respectively. There was a statistically significant association between arthralgia and sex distribution (p=0.0001) where (61.9%) of females had arthralgia. There was a statistically significant association between myalgia and occupation of the patients (p=0.000) where 82.4% of mentally working patients had myalgia. Binary logistic regression analysis revealed significant models for the prediction of myalgia, fatigue and arthritis/arthralgia.Conclusions: Musculoskeletal symptoms associated with COVID-19 patients are frequent mostly fatigue and myalgia followed by arthritis or arthralgia, and back pain. Binary logistic regression analysis revealed significant models for the prediction of myalgia, fatigue and arthritis/arthralgia.